Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Oxford BioMedica
Oxford BioMedica
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Rousselot
Rousselot is the global leader* of collagen-based solutions for the food, health and nutrition, biomedical and pharmaceutical sectors. Working in partnership with our global...
Causes and solutions for dark spots in tablet manufacturing
Natoli Engineering examines the causes and solutions for dark spots that can halt production
Donaldson's Isolere Bio launches IsoTag reagent for optimal AAV purification
The IsoTag AAV reagent can purify adeno associated viruses for research purposes, achieving up to an 85% in yield
Novo Nordisk's haemophilia A/B drug Alhemo gets positive opinion from the EMA
The subcutaneous, self-administering prophylactic can allow a patient to produce thrombin, a clotting agent, even in the presence of inhibitors
groninger showcases filling and closing solutions for OTC pharma at Pack Expo
Discover the flexcare 101 and flexfill machines designed for enhanced efficiency and flexibility in pharmaceutical production
Upcoming event
Lab Innovations
30-31 October 2024 | Exhibition | Birmingham, UK
See all
Related Content
Pharmaceutical
UK vaccine manufacturing nonprofit signs first industry partnership
Oxford Biomedica will be collaborating with VMIC to enable scaled-up manufacture of viral vector-based vaccines
Hi Tech Manufacturing
Oxford Biomedica partners with Microsoft to improve yield of gene therapy via machine learning
Collaboration will see the computing expert develop in silico models and algorithms to address the manufacturing challenges of novel therapies
Recruitment
CGT Catapult addresses skills gap with apprenticeship programme for advanced therapies
Programme will address the projected skills shortage facing public and private employers in the growing cell and gene therapy sector
Design & Build
Oxford BioMedica receives MHRA GMP manufacturing approvals
For lentiviral gene therapy bioprocessing and process development
Design & Build
WHP completes bio-manufacturing facility for Oxford BioMedica
Additional cleanroom space took less than 12 months from concept to completion and creates extra capacity
Manufacturing
Dr Paul Blake becomes Chief Development Officer at Oxford BioMedica
Will take responsibility for the clinical development of pipeline of gene and cell therapies
Research & Development
UK biotechs win Biomedical Catalyst funding of almost £100m
Thirty-three UK companies have received business-led awards
Subscribe now